Ratios Uncovered: Breaking Down Neurocrine Biosciences, Inc. (NBIX)’s Trailing Twelve Months Metrics

Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

The price of Neurocrine Biosciences, Inc. (NASDAQ: NBIX) closed at $133.48 in the last session, down -4.60% from day before closing price of $139.92. In other words, the price has decreased by -$4.60 from its previous closing price. On the day, 1.28 million shares were traded. NBIX stock price reached its highest trading level at $139.49 during the session, while it also had its lowest trading level at $132.84.


We take a closer look at NBIX’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 11.10 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 21.86. For the most recent quarter (mrq), Quick Ratio is recorded 2.47 and its Current Ratio is at 2.52. In the meantime, Its Debt-to-Equity ratio is 0.23 whereas as Long-Term Debt/Eq ratio is at 0.11.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Wells Fargo on April 24, 2024, Upgraded its rating to Overweight and sets its target price to $170 from $140 previously.

On December 12, 2023, Deutsche Bank started tracking the stock assigning a Buy rating and target price of $136.Deutsche Bank initiated its Buy rating on December 12, 2023, with a $136 target price.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 31 ’24 when Delaet Ingrid sold 273 shares for $136.55 per share. The transaction valued at 37,278 led to the insider holds 7,507 shares of the business.

SHERWIN STEPHEN A sold 40,000 shares of NBIX for $5,338,564 on May 29 ’24. The Director now owns 26,504 shares after completing the transaction at $133.46 per share. On May 17 ’24, another insider, POPS RICHARD F, who serves as the Director of the company, sold 2,100 shares for $141.84 each. As a result, the insider received 297,860 and left with 31,611 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NBIX now has a Market Capitalization of 13433026560 and an Enterprise Value of 12633156608. As of this moment, Neurocrine’s Price-to-Earnings (P/E) ratio for their current fiscal year is 36.69, and their Forward P/E ratio for the next fiscal year is 19.17. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.04. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.78 while its Price-to-Book (P/B) ratio in mrq is 5.63. Its current Enterprise Value per Revenue stands at 6.374 whereas that against EBITDA is 25.63.

Stock Price History:

Over the past 52 weeks, NBIX has reached a high of $148.37, while it has fallen to a 52-week low of $91.29. The 50-Day Moving Average of the stock is -3.52%, while the 200-Day Moving Average is calculated to be 5.78%.

Shares Statistics:

According to the various share statistics, NBIX traded on average about 834.86K shares per day over the past 3-months and 923690 shares per day over the past 10 days. A total of 98.70M shares are outstanding, with a floating share count of 98.39M. Insiders hold about 2.24% of the company’s shares, while institutions hold 93.44% stake in the company. Shares short for NBIX as of 1715731200 were 1857466 with a Short Ratio of 2.22, compared to 1713139200 on 2021408. Therefore, it implies a Short% of Shares Outstanding of 1857466 and a Short% of Float of 2.16.

Most Popular